MENU
SLN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Silence Therapeutics (SLN) Earnings Date & Reports

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA... Show more

A.I. Advisor
published Earnings

SLN is expected to report earnings to rise 5.73% to -15 cents per share on March 18

Silence Therapeutics SLN Stock Earnings Reports
Q4'25
Est.
$-0.16
Q3'25
Beat
by $0.04
Q2'25
Missed
by $0.06
Q1'25
Beat
by $0.20
Q3'23
Beat
by $0.10
The last earnings report on November 06 showed earnings per share of -15 cents, beating the estimate of -18 cents. With 224.40K shares outstanding, the current market capitalization sits at 226.72M.
View a ticker or compare two or three
SLN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SLN showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com